Overview

Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus (0431-020)(COMPLETED)

Status:
Completed
Trial end date:
2007-02-02
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Glipizide
Metformin
Pioglitazone
Sitagliptin Phosphate